Phyllodes tumour of the breast: clinical follow-up of 33 cases of this rare disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: European Journal of Obstetrics & Gynecology, and Reproductive Biology, 138, 2, S. 217-221
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2008
- Ereignis
-
Veröffentlichung
- (wo)
-
Amsterdam
- (wer)
-
Elsevier
- (wann)
-
2008
- Urheber
- DOI
-
10.1016/j.ejogrb.2007.08.002
- URN
-
urn:nbn:de:bvb:384-opus4-845189
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lenhard, M. S.
- Kahlert, S.
- Himsl, I.
- Ditsch, Nina
- Untch, M.
- Bauernfeind, I.
- Universität Augsburg
- Elsevier
Entstanden
- 2008
Ähnliche Objekte (12)
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
The significance of HPV in the follow-up period after treatment for CIN
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
Atlas der Brustchirurgie : Operationstechniken Step by Step
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
The significance of HPV in the follow-up period after treatment for CIN
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
Atlas der Brustchirurgie : Operationstechniken Step by Step
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
The significance of HPV in the follow-up period after treatment for CIN
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores